-
of the magnetic reconnection for space propulsion applications, whilst Southampton will focus on the experimental aspects. Using the world class vacuum facilities at Southampton we will develop a magnetic
-
oligonucleotides (ONs) are emerging as a powerful new class of therapeutics for personalised medicine. Through ON-TRACT, we are developing innovative platform technologies that combine the design and synthesis
-
together leading academic, industrial, and clinical partners across Europe. Modified oligonucleotides (ONs) are emerging as a powerful new class of therapeutics for personalised medicine. Through ON-TRACT
-
to world‑class facilities and international collaborators Strong mentorship and career development, including training and conference support Opportunities for collaboration, secondments, and
-
offer An exciting post within a high‑profile UKRI‑funded research programme Access to world‑class facilities and international collaborators Strong mentorship and career development, including training